Clover Health Investments Corp
NASDAQ:CLOV
Clover Health Investments Corp
NASDAQ:CLOV
Price:
1.1 USD
-3.51%
Market Closed
Updated:
Jun 1, 2024
Clover Health Investments Corp
Cash & Cash Equivalents
|
Clover Health Investments Corp
Cash & Cash Equivalents Peer Comparison
Comparables:
UNH
CNC
MOH
HUM
ELV
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Clover Health Investments Corp
NASDAQ:CLOV
|
Cash & Cash Equivalents
$122.9m
|
CAGR 3-Years
64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
UnitedHealth Group Inc
NYSE:UNH
|
Cash & Cash Equivalents
$32.7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
|
|
Centene Corp
NYSE:CNC
|
Cash & Cash Equivalents
$17.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
23%
|
CAGR 10-Years
31%
|
|
|
Molina Healthcare Inc
NYSE:MOH
|
Cash & Cash Equivalents
$4.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
Humana Inc
NYSE:HUM
|
Cash & Cash Equivalents
$5.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
|
Elevance Health Inc
NYSE:ELV
|
Cash & Cash Equivalents
$6.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
See Also
What is Clover Health Investments Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
122.9m
USD
122.9m
USD
Based on the financial report for Dec 31, 2023, Clover Health Investments Corp's Cash & Cash Equivalents amounts to 122.9m USD.
What is Clover Health Investments Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
64%
64%
Over the last year, the Cash & Cash Equivalents growth was 18%. The average annual Cash & Cash Equivalents growth rates for Clover Health Investments Corp have been 64% over the past three years .
You don't have any saved screeners yet
